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neurotoxicity in Parkinson’s disease. The detailed mechanism by which this conversion occurs is largely unknown. Here, we
identify a discrete pattern of transient tertiary interactions in monomeric a-synuclein involving amino acid residues that are, in
the fibrillar state, part of b-strands. Importantly, this pattern of pairwise interactions does not correspond to that found in the
amyloid state. A redistribution of this network of fibril-like contacts must precede aggregation into the amyloid structure.INTRODUCTIONIn many neurodegenerative amyloid-linked human condi-
tions, such as Alzheimer’s and Parkinson’s diseases, fibril
formation proceeds via crucial steps that involve monomer
to oligomer transition, oligomer maturation, and amyloid
formation (1). Recent studies suggest that a complex struc-
tural reorganization of the implicated proteins along this
process governs neurotoxicity (2–4). However, the precise
nature of this conformational rearrangement remains
elusive. In this work, we sought to shed light on the early
stages of the amyloid pathway of the intrinsically disordered
protein (IDP) a-synuclein (aS), a presynaptic protein
involved in Parkinson’s disease (5). Recent evidence indi-
cates that in vivo aS may coexist between an aggregation-
prone monomeric disordered state, an aggregation-resistant
tetrameric helix-rich conformation, a helical vesicle-bound
state, and different b-sheet-rich species of prefibrillar and
fibrillar nature (6–9). Although the structure of aS fibrils
has not been unambiguously determined at atomic resolu-
tion due to fibril polymorphism (10), the most accepted
model suggests that in its fibrillar state aS monomers adopt
an antiparallel in-register five b-strand fold (b1 to b5) with
monomer units stacked in a parallel fashion forming the
fibril protofilament (11). Such structural plasticity has stim-
ulated research toward the structural characterization of aS,
which has now become the prototypical example of an IDP.
Despite being largely disordered in solution, monomeric
aS is known to populate collapsed conformations (12–14),
which are associatedwith an increase in the rate of protein ag-
gregation (12,14). Several authors have identified the presence
of long-range interactions in the protein that put in contact
distant regions of the protein (15–20). Studies of the protein
in aggregation-prone conditions suggest that these contacts
may play a key role in the control of self-oligomerizationSubmitted March 22, 2013, and accepted for publication July 25, 2013.
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0006-3495/13/09/1192/7 $2.00(15,20,21). Tertiary contacts are thus a fundamental structural
feature of this protein that underlies conversion of aS into a
neurotoxic, likely b-sheet rich, conformation. NMR studies
of soluble aS in supercooling conditions have demonstrated
that the monomeric protein transiently populates b-strand-
rich conformationswithin its fibril-forming domain, as judged
by negative secondaryCa andC0 deviations aswell as positive
secondary 3J(HNHa) couplings (22). No transient tertiary in-
teractions between residues forming b-strands in the amyloid
state have yet been described in the monomeric state of the
protein; however, close examination of NMR (15–17),
single-molecule Fo¨rster Resonance Energy Transfer (FRET)
(18,19), and electron transfer kinetics data (20) suggest a
more complex pattern of transient tertiary interactions in solu-
tion than the one identified so far (Fig. 1, a and b).
Here, we mapped at high resolution this network of tran-
sient tertiary interactions present in the soluble monomeric
state of aS and found a fingerprint of its amyloid fibrillar
structure. To calculate a high-resolution interresidue contact
map of aS, we employed an extensive set of intramolecular
paramagnetic relaxation enhancement (PRE) data for the
monomeric state of the protein (15,16,23,24). PREs are an
extremely powerful NMR parameter for detecting long-
range transiently formed contacts in IDPs due to the highly
nonlinear distance-dependent enhancement of relaxation
rates in nuclei induced by the presence of paramagnetic
spin probes (25). Our contact map of aS provides novel,
to our knowledge, insights into the relationship between
the structural properties of amyloid fibrils and those of their
monomeric precursors as well as on the conformational
changes that occur during amyloid formation.MATERIALS AND METHODS
Intramolecular PRE data
PRE-derived interresidue distance restraints for aS at pH 7.4 were collected
from works published by leading laboratories in the study of the structuralhttp://dx.doi.org/10.1016/j.bpj.2013.07.044
FIGURE 1 High-resolution mapping of tertiary contacts in monomeric
aS. (a) Spin labeling of single Cys-containing aS variants with MTSL leads
to mapping of tertiary contacts by NMR. Nuclei within a distance of up to
25 A˚ from the PRE label suffer attenuation of its NMR intensity, which is
proportional to r6. Positions of PRE labels used in the structure calcula-
tions are shown in red. (b) Left panel: Experimental PRE data (red) and
fitted PRE data (black) are shown for a representative position of the
MTSL label (76-MTSL). The expected profile for a random coil is shown
in gray. Tertiary contacts are highlighted by arrowed dashed lines. Right
panel: Results of the structure calculation procedure that best fit the data.
Forty independent calculations were performed and the structures were
pooled before contact map analysis. (c) Interresidue Ca-Ca contact map
resulting from the structure calculations. Contact fraction denotes the num-
ber of conformers from the pool that contain a given contact. Contacts pre-
viously reported in the literature are highlighted as Known contacts
(15,16,20). Contacts discovered in this work are highlighted as Novel con-
tacts.
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17,23). In total, we analyzed 1104 intensity ratios arising from 11 spin
probes (MTSL: (S-(2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)meth-
ylmethanesulfonothioate) located at various positions along the polypeptide
chain (amino acids 18, 20, 24, 42, 62, 76, 85, 87, 90, 103, and 140). Under
these experimental conditions of low temperature and low concentration,
aS remains monomeric and no oligomerization is detectable by any
ensemble spectroscopic method or by control intermolecular PREs experi-ments employing mixtures of PRE-tagged 14N protein and untagged 15N
protein (16). Because of this experimental setup, we can be confident that
PRE effects arise predominantly from intramolecular interactions, however
we cannot completely rule out a marginal contribution of intermolecular na-
ture arising from transient low order oligomeric species (26) (see discussion
in the Supporting Material). A scaling factor had to be introduced in the
case of some PRE labels to compensate for slight variations in experimental
conditions between data sets, temperature, and reduction of the MTSL la-
bel. Scaling factors were determined by normalization of each data set to
their respective average values. Scaling factors applied were 1.17 for labels
at positions at 18, 90, and 140 (15); 1.25 for labels at positions 20 and 85
(17); 1.0 for positions 24, 42, 62, 87, and 103 (16); and 1.0 for the label
at position 76 (23).Determination of contacts maps
Structure calculations were performed using full-atom Monte Carlo (MC)
simulations method guided by PRE experimental restraints (27) (see
extended details in the Supporting Material, Supplementary data). The
calculation method was benchmarked with synthetic PRE data generated
for the protein aS, as well as other intrinsically disordered and chemically
denatured proteins (27). PRE intensity ratios on HN atoms (intensity ratio
between 1H-15N amide crosspeaks in oxidized and reduced states of the spin
label) were calculated at each MC move. The MTSL spin label was explic-
itly built and rotated at each step to sample the accessible conformational
space. Calculations were performed for ensembles sizes of 1, 2, 5, 10,
20, and 50 conformers (see Fig. S4). The calculation procedure was
repeated 40 times for each ensemble size and structures were pooled before
contact map analysis. For ensemble size 1 (7.8 restrains/amino acid), data
were fitted within experimental error (R2 ¼ 0.96, root mean-square devia-
tion (rmsd) ¼ 0.09). Only a marginal increment in the goodness of the fit
was obtained for ensemble sizes larger than 1 (Drmsd ¼ 0.01). As shown
before, due to the r6 weighted averaging of the PRE effect, employing a
limited number of conformers to satisfy the PRE distance restraints avoids
the presence of unrestrained conformers (28). Energy minimization of the
structures determined using the AMBER force field in GROMACS (29)
left the calculated structures virtually unchanged. Ca-Ca contact maps
were generated by pooling 40 structures obtained from independent runs,
which formed a well-defined cluster of conformations. A contact was
defined as a Ca-Ca interresidue distance up to 20 A˚ (range of PRE action).
The contacts reported for the fibril correspond to ssNMR data previously
reported (11). This data considers contacts between residues within 6 A˚,
which have been extracted from 13C–13C proton-driven spin diffusion
spectra (experiment with a mixing time of 250 ms).Physicochemical characteristics of the primary
sequence of aS
Data were generated using the Expasy protscale server (http://web.expasy.
org/cgi-bin/protscale/protscale.pl). Hydrophobicity at pH 7.5 obeys the
scales reported by Cowan et al (30). A sliding average window of seven res-
idues was employed. The profile of predicted amyloid aggregation follows
the commonly used algorithms WALTZ (high sensitivity filter) and Zyggre-
gator (Zagg) (31,32).RESULTS
As a starting point in our calculations, we collected a large
set of intramolecular PRE data from 11 paramagnetic labels
previously measured for monomeric aS under conditions
that minimize the presence of oligomeric species (pH 7.4,
100 mM protein concentration, temperature of 10 toBiophysical Journal 105(5) 1192–1198
FIGURE 2 Fibril-like contacts are present in soluble monomeric aS. (a)
Overlay of contacts determined by ssNMR in the amyloid core of aS fibrils
(black dots) with fibril-like contacts described for soluble aS in this work.
b-strands found in the fibrillar core are depicted as grayscale arrows
numbered 1 to 5. (b) Frequency of contacts established by residues within
the amyloid core of aS in its soluble state (red line) and in the fibril (black
line). Contacts established by residues of the region 30–100 are considered
in this analysis.
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implemented a scaling factor (Table S1). Thus, our calcula-
tion strategy employs a total of 1104 distance restraints, two
to three times the number of PRE restraints used in previous
analysis of the protein (15,16,23,24). The interresidue con-
tact map was derived by fitting the PRE data to structural
models by using a full-atom MC structure calculation
method that we recently developed (27) (Fig. 1 c, Fig. S1,
and Supplementary data). It is important to clarify that aS
populates an ensemble of rapidly interconverting conforma-
tions in solution and, therefore, the interresidue contact map
is a projection of all tertiary interactions, populated up to a
few percent by the disordered state of the protein, which
may not be simultaneous.
The interresidue contact map we determined for aS high-
lights with unprecedented detail previously known long-
range interactions between the C-terminus of the protein
with both the N-terminal and central parts of the protein,
termed NAC (Fig. 1 c, Known contacts and Fig. S3)
(15,16,20). We find that the C-terminal region possesses a
strong avidity for establishing interactions: the region 124
AYEMPSEEGYQDYEP138 contacts residues 1MVDFM
KGLMK10, whereas the region comprising residues 104
EEGAPQEGILEDMPVDPNEAYEMPSE130 interacts with
three segments involving residues 38LYVGSKTKEGVV
HGVATVA56, 74VTAVAQK80, and 90AATGFVKKDQL100.
The charged nature of these regions underlies their contact
tendency.
Due to the high resolution achieved in our calculations, a
number of short-range contacts could also be resolved indi-
cating a strong degree of collapse present at both the N- and
C-terminal regions of the protein (Fig. 1 c). At the N-termi-
nus, the collapsed state spans up to residue 30, which could
reflect the population of conformations with nascent helical
content because this region folds into an a-helix upon olig-
omerization or in the presence of phospholipids (33).
Indeed, studies of 15N relaxation and secondary chemical
shifts indicate partial population of helical conformations
by this domain in the momomeric state of the protein
(34,35). The collapse at the C-terminus is centered on resi-
due 120, the region with the highest degree of residual struc-
ture in the protein, as judged by unusually high NMR
residual dipolar couplings (15), and being also a major
metal binding site (36).
Most notably, our high-resolution contact map reveals an
up to now unreported pattern of transient tertiary interac-
tions in aS (Fig. 1 c, Novel contacts, Fig. S3). A compara-
tive analysis with ssNMR data measured for aS fibrils
indicates that these contacts involve amino acids that form
the b-strands within the amyloid fibril core of aS (b1 to
b5), therefore we termed these fibril-like contacts (Fig. 2,
a and b). In Fig. 2 we compare the tertiary contacts found
in solution with contacts derived from the ssNMR model
of the fibril. According to ssNMR, H/D exchange mass
spectrometry and electron paramagnetic resonance data,Biophysical Journal 105(5) 1192–1198the amyloid core of the fibril comprises, approximately, res-
idues 30 to 100 (11,37,38). Therefore, we decided to focus
our analysis on this stretch of residues. From this figure it is
noteworthy that, although some of these fibril-like interac-
tions correlate directly with contacts established in the
amyloid fold of aS, referred to here as fibrillar contacts,
the remaining establish a mismatched pattern of pairwise in-
teractions with respect to the arrangement found in its amy-
loid state, referred to herein as nonfibrillar contacts (Fig. 2
a, Fig. 3 a). Among the fibrillar contacts, we were able to
resolve tertiary contacts between b1–b2 and b4–b5, two
fibril-like interactions that could seed amyloid conversion.
We cannot exclude contacts between b2–b3–b4, which are
likely to occur, but could not be resolved due to the short-
range nature of these contacts and the presence of overlap-
ping interactions.
As mentioned, we also detected in monomeric aS a
pattern of nonfibrillar contacts between residues that
are, in the fibrillar state, part of b-strands. The most re-
markable of such interactions involves the stretch of resi-
dues 35EGVLYV40 contacting residues 70VVTGVTAVA78.
These two regions correspond to b1 and b4 strands of the
amyloid fibril (Fig. 2 a, Fig. 3 a) and contain Tyr39 and
the stretch of hydrophobic residues 71–82, both known to
be critical for fibril formation (39,40). We also observed
FIGURE 3 Reorganization of contacts between b-strands during aggre-
gation of aS. (a) Overview of contacts described for soluble aS in this
work. The regions involved in the establishment of each particular contact
are identified with green labels if they are off the aggregation pathway (N-
terminus, NAC, C-terminus) or with red if they are on the aggregation
pathway (strands b1 to b5). (b) Fibril-like contacts are established between
hydrophobic regions predicted as highly amyloid prone. Predictions for aS
aggregation computed byWALTZ (amyloid-forming regions, blue line) and
Zyggregator (Zagg, amyloid aggregation propensity, red line). Hydropho-
bicity is shown as a black dashed line. (c) Our high-resolution contact
map for monomeric aS suggests that residues within the fibril-forming
domain of the protein adopt a different spatial arrangement in solution
than in the fibrillar state, demanding structural reorganization of contacts
between residues in b-strands before amyloid formation. Such reorganiza-
tion would probably take place at the level of oligomeric and prefibrillar
species.
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correspond to strands b1–b3, b2–b4, and b2–b5 in the
amyloid fibril. Nonfibrillar interactions established by these
residues are mismatched contacts that would require reorga-
nization before fibril formation, similar to nonnative interac-
tions that modulate the folding of certain globular proteins
(41–45).
A close analysis of the nature of the regions involved in
establishing fibril-like contacts in soluble monomeric aS
indicates that these interactions are of hydrophobic nature
and engage residues commonly found in intermolecularcomplexes involving IDPs (46). Note that these hydropho-
bic regions form a discrete pattern of contacts instead of
an all-to-all interacting pattern, suggesting a complex hier-
archy in the establishment of tertiary interactions. Fibril-
like contacts appear to be modulated by amino acid regions
with a high propensity to aggregate into amyloid fibrils,
according to the predictions made by two commonly used
algorithms (31,32) (Fig. 3 b), and further validated by exper-
imental data (39,40).DISCUSSION
The investigation of aggregation-prone conformations
populated in the monomeric ensemble of amyloidogenic
IDPs such as aS, Tau, or Ab aims to identify structural ele-
ments that could initiate protein misfolding and aggregation
in pathologies such as Alzheimer’s and Parkinson’s. During
the last years a large number of research groups have imple-
mented NMR and computational methodologies to charac-
terize such heterogeneous conformations with atomic
detail (47). In the absence of persistent secondary structure,
one of the primary elements that restrict the conformations
populated by IDPs is tertiary interactions, which are
detected by NMR methodologies such as PREs (48). With
the aim of uncovering low populated contacts that were pre-
viously not identified in aS, in this work we characterized
tertiary contacts present in the monomeric state of the pro-
tein that are consistent with a large set of intramolecular
PRE data. Indeed, our contact map allowed us to describe
for the first time, to our knowledge, tertiary interactions pre-
sent in the soluble state of aS that arise from regions of
sequence involved in the cross-b core of the fibrils, but
that do not correspond to those found in the amyloid state
(Fig. 3). Although we positively identified fibrillar contacts
between residues forming b1–b2 and b4–b5 strands, we
also found nonfibrillar contacts between residues embedded
in b1–b4, b1–b3, b2–b4, and b2–b5 strands of the amyloid
fibril. Importantly, close examination of the PRE profiles
shows that all of these interactions are indeed present in
the experimental data and are not a consequence of the
structure calculation protocol (Fig. S3).
These findings have mechanistic implications for the cur-
rent knowledge of the fibrillation pathway of aS. Intramo-
lecular long-range N/C-terminal tertiary interactions in the
soluble state of aS have been proposed to maintain the
monomeric protein in an autoinhibited, less aggregation-
prone conformation (15,16,20). These contacts thus lie off
the pathway of amyloid aggregation (Fig. 3 a). The transient
tertiary contacts between hydrophobic regions participating
in the fibril core of the protein would, by contrast, direct the
formation of early aggregation-prone species (Fig. 3 a).
Conceptually related to a folding nucleus, these contacts
would lead to the buildup of metastable species rich in
cross-b structure but with a network of interresidue interac-
tions different to that of mature fibrils (3,11).Biophysical Journal 105(5) 1192–1198
1196 Esteban-Martı´n et al.According to our model, initial oligomerization would
then be followed by a step where such network reorganizes
to lead to the thermodynamically stable 5 b-strand fold of
the amyloid fibril. Spectroscopy studies indicate that initial
steps of aS aggregation give rise to prefibrillar oligomeric
species that have different b-sheet signatures than mature
amyloid fibrils, as judged by ssNMR and FTIR (49,50). In
addition, single-molecule FRET studies showed that the
structural conversion between oligomeric forms of aS into
b-sheet-rich oligomers is remarkably slow and progresses
through a rough energy landscape as a result of multiple
possibilities of interstrand interactions (3). All this experi-
mental evidence is consistent with our finding that structural
signatures of soluble and fibrillar aS species would have a
different b-strand arrangement (Fig. 3 c). In the broad
context of protein misfolding and aggregation, our data sug-
gests that on-pathway oligomeric intermediates may be
stabilized by nonfibrillar contacts akin to the nonnative
interactions that stabilize certain folding intermediates in
globular proteins (41–45). Such nonfibrillar contacts sustain
the idea of a rugged energy landscape in the misfolding and
aggregation of proteins (51). It could be of particular interest
to unravel this proposed mechanism experimentally by, for
example, enforcing some of these contacts by covalent link-
age of Cys-containing mutants of aS. Such a procedure was
recently applied to the Ab peptide and yielded novel
insights into the earliest stages of aggregation (52). In an
analogous fashion it should be possible to isolate and char-
acterize the transient oligomeric intermediates formed by
aS by stabilizing the nonfibrillar contacts that we discovered
in this work.
We note that antiamyloidogenic agents that target mono-
meric aS have been recently shown to interact with Tyr39
(b1) or key hydrophobic residues in the central part of the
protein (b4 and b5) (39,53–55). Mostly of polyphenolic
nature, these agents establish p-p stacking interactions
with the side chain of Tyr39 and interact in a rather unspe-
cific manner with the stretch of hydrophobic residues
comprising amino acids 70–90. In light of our data, it is
then possible that such small molecules prevent crucial
structural rearrangements to take place at the level of the
monomeric protein by inhibiting some of the long-range
fibrillar contacts established between residues that compose
the b-strand regions of the fibril. Identification of such
regions that are necessarily brought into spatial proximity
to set off protein aggregation should facilitate the design
of novel, to our knowledge, small molecules that could
modulate fibril formation.
The intra- versus intermolecular nature of tertiary N/C
interactions provides an increased layer of complexity in
the aggregation pathway of aS. Here, we mapped with
high resolution the intramolecular N/C-terminal interactions
occurring at the level of the monomeric protein. Notably,
intermolecular PRE studies of partially oligomeric aS
(1.1 mM protein concentration) showed transient interchainBiophysical Journal 105(5) 1192–1198N/C-terminal interactions involving residues 1–15/120–140
and 35–45/120–140, precisely two of the main interactions
detected in our contact map of the monomeric protein (26).
In this regard, it was previously shown that ligands that bind
the C-terminus trigger protein aggregation by release of the
intramolecular N/C interactions (15), and more recently
fluorescence spectroscopy evidenced local structural reorga-
nization at both the N- and C-termini preceding oligomeri-
zation (56). Moreover, measurements of intrachain diffusion
rates in aS monomers showed that intramolecular reconfi-
guration of tertiary contacts determines the kinetics of
bimolecular association (57). It is then evident that residual
structure at both the N- and C-terminus, and its interplay via
long-range interactions, appears to govern the early steps in
aS oligomerization. The possibility of swapping between
intra- and intermolecular contacts while remaining disor-
dered offers a rationale for the initial population of oligo-
meric species in the amyloid pathway of aS with minimal
energetic costs. Even when these regions are not directly
involved in the fibrillar core of the protein, they seem to
communicate via intrachain contacts to dictate the confor-
mations populated by the protein. For example, nitration
of C-terminal Tyr residues perturbs binding of the N-termi-
nus to lipid membranes via a yet unknown mechanism that
could, very likely, involve reorganization at the level of N/C
interactions (19).
The unexpected complexity in the nature and function-
ality of the network of short- and long-range tertiary inter-
actions of monomeric aS could have implications for our
future understanding of the biological relevance of such
transient structural features in IDPs. From this work it is
noticeable that a high-resolution description of tertiary con-
tacts using small ensembles is a very valuable complemen-
tary study to the use of large ensembles (47,48,58,59).
Although the latter approaches allow a more general
description of the vast conformational space populated by
the disordered protein, our methodology allows identifying
with higher precision biologically relevant contacting re-
gions of the polypeptide chain. In particular, the description
of fibril-like interactions in monomeric aS could allow bet-
ter identification and targeting of aggregation-prone species
within the ensemble of aS conformations.SUPPORTING MATERIAL
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